✦ LIBER ✦

S1477: Should We Still Ablate the Residual Barrett's Mucosa After Successful EMR of a Neoplastic Lesion in Barrett's Esophagus

✍ Scribed by Yutaka Tomizawa; Ganapathy A. Prasad; Louis-Michel Wong Kee Song; Navtej Buttar; Ngozi I. Okoro; Vikneswaran Namasivayam; Marlys Anderson; Kelly T. Dunagan; Lynn S. Borkenhagen; Lori S. Lutzke; Kenneth K. Wang

Book ID: 119249178
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 86 KB
Volume: 71
Category: Article
ISSN: 1097-6779
DOI: 10.1016/j.gie.2010.03.251

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

S1487: What Should We Do With the Remain

S1487: What Should We Do With the Remainder of the Barrett's Segment After Endoscopic Resection of Early Barrett's Cancer? Intermediate Results of the First Prospective-Randomized Trial on the APC Ablation of Residual Barrett's Mucosa With Concomitant Esomeprazole Therapy Versus Surveillance Without Ablation After ER of Early Barrett's Cancer

✍ Hendrik Manner; Thomas Rabenstein; Kirsten Braun; Andrea May; Oliver Pech; Juerg 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 90 KB

3 Predictors of recurrent Barrett's esop

3 Predictors of recurrent Barrett's esophagus after successful radiofrequency ablation in a nationwide, multicenter cohort: Results from the U.S. RFA Registry.

✍ Bulsiewicz, William J.; Dellon, Evan S.; Lyday, William D.; Ertan, Atilla; Camar 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 97 KB